Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jun 7, 2014; 20(21): 6470-6480
Published online Jun 7, 2014. doi: 10.3748/wjg.v20.i21.6470
Published online Jun 7, 2014. doi: 10.3748/wjg.v20.i21.6470
Selection of a TIPS stent for management of portal hypertension in liver cirrhosis: An evidence-based review
Xing-Shun Qi, Ming Bai, Zhi-Ping Yang, Dai-Ming Fan, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi’an 710032, Shaanxi Province, China
Xing-Shun Qi, Department of Gastroenterology, No. 463 Hospital of Chinese PLA, Shenyang 110045, Liaoning Province, China
Author contributions: Qi XS designed the study, performed the literature retrieval, analyzed the data, and drafted the paper; Bai M, Yang ZP and Fan DM revised this review; all authors approved the submission.
Correspondence to: Dai-Ming Fan, MD, PhD, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xincheng District, Xi’an 710032, Shaanxi Province, China. fandaim@fmmu.edu.cn
Telephone: +86-29-84771501 Fax: +86-29-82539041
Received: October 27, 2013
Revised: January 18, 2014
Accepted: February 17, 2014
Published online: June 7, 2014
Revised: January 18, 2014
Accepted: February 17, 2014
Published online: June 7, 2014
Core Tip
Core tip: This review suggests the following: first, a 10-mm stent may be more effective than an 8-mm or 12-mm stent for the management of portal hypertension in liver cirrhosis; second, Viatorr covered stents may be recommended for maintaining the shunt patency; finally, the placement of a transjugular intrahepatic portosystemic shunt stent in the left portal vein branch may be more reasonable for decreasing the development of hepatic encephalopathy.